The mechanism of extracellular adenosine 5'-triophsphate (ATP)-triggered vagal depressor reflex was further studied in a closed chest canine model. Adenosine and ATP were administered individually in equimolar doses (0.01-1.0 :mol/kg) into the right (RCA) and left circumflex (LCA) coronary arteries. When given into the RCA, adenosine and ATP exerted an identical and relatively small negative chronotropic effect on sinus node automaticity; the time-to-peak-effect of which was >7 sec. When given into the LCA, adenosine was without effect while ATP markedly suppressed sinus node automaticity. This effect of ATP, (i) reached its peak in less than two seconds following its administration, (ii) was short lasting and (iii) was completely abolished by either intravenous administration of the muscarinic cholinergic blocker atropine (0.2 mg/kg) or intra-LCA administration of 2',3'-O-(2,4,6-trinitrophenyl)-ATP (TNP-ATP), a potent P2X 2/3 purinergic receptor (P2X 2/3 R) antagonist, but not by diinosine pentaphosphate (Ip 5 I), a potent inhibitor of P2X 1 R and P2X 3 R. Repetitive administrations of ATP were not associated with reduced effects indicative of receptor desensitization, thereby excluding the involvement of the rapidly desensitized P2X 1 R in the action of ATP. It was concluded that ATP triggers a cardio-cardiac vagal depressor reflex by activating P2X 2/3 R located on vagal sensory nerve terminals localized in the left ventricle. Since these terminals mediate vasovagal syncope, these data could suggest a mechanistic role of extracellular ATP in this syndrome, and in addition, give further support to the hypothesis that endogenous ATP released from ischemic myocytes is a mediator of atropine sensitive bradyarrhythmias associated with left ventricular myocardial infarction.
INTRODUCTION
Extracellular adenosine 5'-triphosphate (ATP), the ubiquitous adenine nucleotide, acts as a physiologic regulator of the cardiovascular system by activating cell surface receptors (23) . The latter are called P2 purinergic receptors (P2R), distinct from the P1, the adenosine receptors (P1R) (26) . P2R are divided into two families: P2X, ligand activated cationic channels, and P2Y, G protein coupled seven trans-membrane domain receptors; fifteen P2R have been cloned heretofore. An orphan G protein-coupled receptor with homology to the P2YR family activated by both adenosine and adenosine 5'-monophospahte (AMP) (termed, P2Y15), and found mainly in human lung mast cells has been most recently cloned (11) . In the heart, ATP exerts negative chronotropic action on sinus node's and ventricular pacemakers' automaticity as well as a negative dromotropic action on atrio-ventricular (AV) nodal conduction (18, 20) . These actions of ATP are mediated by adenosine, the product of ATP's rapid degradation by ectonucleotidases and by a vagal reflex; when vagal involvement is prevented (e.g., bilateral cervical vagotomy, or atropine), equimolar doses of adenosine and ATP cause similar slowing of heart rate (18, 22) .
Our earlier studies attempted to localize the anatomical site at which ATP triggers the vagal reflex as well as determine the type of receptor that mediates the negative chronotropic action of ATP in the canine heart (10, 12, 13, 20, 21) . The following observations in these studies have suggested that the site of ATP's action is in the left ventricle: (i) given directly into the sinus nodal artery, ATP is equipotent to adenosine and its action is devoid of a vagal component, (ii) ATP given into either the left main (LM), left circumflex (LCA) or left anterior descending (LAD) coronary artery exerted a vagal-dependent negative chronotropic effect on sinus node automaticity; the sitepotency rank order of this effect was LM>LCA>LAD, (iii) doses of intracoronary ATP (i.e., 0.1-1.0 µmol/kg) that exerted vagal-dependent negative chronotropic effects were below the threshold dose of intra-right atrial (RA) ATP for triggering a vagal reflex, (iv) the negative chronotropic action of intra-RA ATP was not affected by pulmonary denervation, (v) ATP administered into the carotid artery or descending aorta did not trigger a vagal reflex, (vi) the site-time to peak effect rank order was as follows: RA>aortic root>intra-coronary, (vii) bilateral cervical vagotomy abolished the negative chronotropic effect of intra-coronary ATP but only attenuated that of intra-RA ATP, and (viii) the site-potency rank order for a given dose of ATP was intra-left coronary artery>aortic root>intra-RA. Regarding the type of P2R that mediates the stimulatory action of extracellular ATP on vagal afferent nerve terminals, the potency rank order of ATP and its analogs has suggested mediation by a P2X purinergic receptor subtype (P2XR).
The goals of the present study were: (i) to confirm that the left ventricle is the sole site in the canine heart at which extracellular ATP activates vagal afferent nerve terminals, and (ii) to determine the P2X receptor subtype that mediates the action of ATP. For this purpose, the negative chronotropic actions of adenosine and ATP, given at equimolar doses into the RCA and LCA were quantified, and the effects of two P2XR antagonists, diinosine pentaphosphate (Ip 5 I), a P2X 3 R antagonist, and 2',3'-O-(2,4,6-trinitrophenyl)-ATP (TNP-ATP), an antagonist of the heteromeric P2X 2/3 R, and the muscarinic cholionergic receptor blocker, atropine, on the negative chronotropic action of intra-LCA ATP, were determined in a closed chest canine model. Present data support the hypothesis that extracellular ATP triggers a cardio-cardiac vagal depressor reflex by activating P2X 2/3 R located on vagal sensory nerve terminals localized in the left ventricule of the canine heart.
Preliminary report of the present data has been previously published in an abstract form (24) .
MATERIALS AND METHODS
The Institutional Animal Use and Care Committee of Drexel University College of Medicine had approved the experimental protocol.
Experimental Model: Mongrel dogs of either sex (n=13; 24+2 kg) were sedated with acepromazine (0.2 mg/kg, i.m.), anesthetized with sodium pentobarbital (30 mg/kg + 3 mg/kg/hr, i.v.), intubated with an endotracheal tube, and ventilated with room air supplemented as necessary with O 2 using a Harvard respirator. A thermal mattress was used to maintain body temperature at a physiologic range; body temperature was monitored with a rectal thermometer. Heparin (50 U/kg, i.v.) was given to prevent thrombus formation. A peripheral vein was cannulated for the administration of the anesthetic, atropine and physiologic saline solution. An electronic pressure transducertipped catheter (Millar) was inserted via the left femoral artery and positioned in the descending aorta. Several catheters, introduced via a Deseret sheath positioned in the right femoral artery, were used for intracoronary injections of adenosine, ATP, Ip 5 I and TNP-ATP.
Intracoronary administration of test compounds:
The following catheters were used for the administration of the test compounds: LCA: Judkins left coronary diagnostic catheter (JL3, 6F; Cordis, Miami FL) and a Judkins left coronary guiding catheter (JL3.5, 6F; Cordis). RCA: Judkins right coronary guiding catheter (JR 3.5, 6F, Cordis) and internal mammary catheter (6F, Cordis). ISOVUE-370 contrast media and Philips BV29 fluoroscopy system were used for coronary angiography and positioning of catheters.
Protocol: After a stabilization period of 30 min, adenosine and ATP (0.1 :mol/kg) and control (physiologic saline solution) were administered at random initially into the right coronary artery and subsequently, into the LCA. When given into the LCA, two additional doses of adenosine and ATP were used: 0.01 and 1.0 :mol/kg. ATP was administered into the LCA also before and after intra-LCA Ip 5 I (5 mg) or TNP-ATP (5 mg), and intravenous atropine (0.2 mg/kg). Our previous studies have shown that adenosine and ATP at a dose of 0.1 :mol/kg are devoid of any effect on either sinus node automaticity or AV nodal conduction when given systemically (i.e., intravenously). Ample time was given for the recovery of baseline conditions between consecutive injections whenever necessary. Only one antagonist (i.e., TNP-ATP, Ip 5 I or atropine) was used in a given animal.
Data acquisition and analysis:
The following parameters were monitored and recorded using Gould Data Acquisition System (#5900), TEAC tape recorder (XR-5000), Dell Computer (Precision 410), Data acquisition software (Dataq), and Astromed (#9500) chart recorder: Standard lead I and II electrocardiograms (ECG), systemic arterial blood pressure, and blood pH, PO 2 
RESULTS
Baseline data: Following the stabilization period SCL was 445+23 msec and systolic BP was 149+6 mmHg (n=13).
Intra-RCA adenosine and ATP:
Due to the relatively small size of the RCA in the dog, successful uncomplicated positioning of the intra-coronary infusion catheter was achieved in limited number of animals. Given at a low dose (0.1 :mol/kg) as a bolus injection into the right coronary artery, ATP and adenosine had a negligible effect on sinus node automaticity, i.e., %)SCL of 31+30 and 23+16 (n=5) (p=NS), respectively; at higher dose of 1.0 :mol/kg, the effect was 38 and 130 (n=2), respectively. Irrespective of the dose, the time to peak effect after the administration of ATP and adenosine was always seven to ten seconds (as compared to less than two seconds for intra-LCA administration; see below). Control (physiologic saline solution; same volume as that of the test compound solutions) injections were without effect.
Intra-LCA adenosine and ATP: Intra-LCA adenosine did not significantly affect sinus node automaticity, specifically, at dose of 0.01, 0.1 and 1.0 :mol/kg, %)SCL was 1.0 (n=2), 6+4 (n=8), and 14+14 (n=3), respectively (p=NS). In contrast, ATP given at a molar dose equivalent to that of adenosine, exerted a pronounced dose dependent negative chronotropic effect on sinus node automaticity, manifested in marked abrupt prolongation of SCL. A typical example of the effects of intra-right coronary artery and intra-LCA adenosine and ATP (0.1 :mol/kg) is shown in Figure 1 . As can be seen neither adenosine nor ATP affected sinus rate when given into the right coronary artery; similarly, intra-LCA adenosine had no effect on sinus rate. In contrast, intra-LCA ATP had a pronounced transient negative chronotropic effect which peaked in less than two seconds following its administration. After 0.01, 0.1 and 1.0 :mol/kg ATP %)SCL was 116+34 (n=3), 162+28 (n=12), and 203+35 (n=6) (each, p<0.05; Figure 2 ). This effect of ATP was rapid in onset, i.e., <2 sec following its administration, and short lasting. The pattern of an abrupt prolongation of PP interval was suggestive of sinus exit block induced by ATP. Repetitive administrations of ATP exerted reproducible effects indicating lack of desensitization of the mediating receptor. Control (physiologic saline solution; same volume as that of ATP solution) injections were without effect.
Blood Pressure: Transient drop in blood pressure was observed subsequent to the injections of either ATP or adenosine in either the RCA or LCA ( Table 1 ). The time to peak effect was 11-12 sec; significantly (p<0.05) longer than the time to peak effect of ATP on heart rate (< 2 sec), indicating that these effects were mediated by the direct dilatory actions of ATP and adenosine on the peripheral resistive vasculature. 5 I and atropine: Intra-LCA TNP-ATP completely abolished the negative chronotropic effect of the low dose of ATP (0.01 :mol/kg; n=2) and markedly attenuated that of 0.1 :mol/kg; i.e., %)SCL was reduced from 179+30 to 27+12 (n=5, p<0.05). A typical example of the effect of TNP-ATP on the chronotropic action of ATP (0.01 :mol/kg) is shown in Figure 3 . As can be seen, basic sinus cycle length of 640 msec (upper panel) was maximally prolonged to 1260 msec (middle panel); when ATP was given again 20 sec after TNP-ATP (5 mg; Intra-LCA bolus), it had no effect (lower panel). The inhibitory action of TNP-ATP was transient such that the negative chronotropic action of ATP gradually returned to its original magnitude. Similarly, after intravenous administration of atropine (0.2 mg/kg), ATP was without any effect. In contrast, intra-LCA Ip 5 I did not alter the effect of ATP (data not shown).
Effects of TNP-ATP, Ip

DISCUSSION
New information:
The present results suggest that the heteromeric P2X 2/3 R located on left ventricular vagal nerve terminals mediates the central reflex triggered by intra-LCA ATP. Since these nerve endings are considered to play a critical mechanistic role in neurallymediated syncope, it is tempting to speculate that extracellular ATP is involved in this syndrome. In addition, it can be proposed that ATP, released into the extracellular space from ischemic myocytes, is an endogenous mediator of atropine-sensitive bradyarrhythmias associated with infero-posterior wall myocardial infraction.
Background and previous findings: Extracellular ATP is a physiologic regulator in the cardiovascular system; in the heart, ATP exerts pronounced negative chronotropic and dromotropic actions on cardiac pacemakers and AV nodal conduction, respectively (23) . Two decades ago, we showed that these effects of ATP are mediated by adenosine, which is the product of ATP's rapid degradation by ecto-nucleotidases, and by a central vagal reflex; when vagal involvement was excluded (e.g., bilateral cervical vagotomy, atropine pretreatment), ATP and adenosine were equipotent (17, 18) . Since then, we have been studying the vagal component of ATP's action in the canine heart with the objectives: (i) to determine the anatomical site at which ATP triggers the afferent neural traffic to the medulla, and (ii) identify the type of receptor that mediate this action of ATP (10, 12, 13, 21) . Data obtained in these studies have suggested that ATP stimulates vagal sensory nerve terminals localized in the left ventricle of the canine heart and that this action is mediated by P2X receptors. The present data give further support to this interpretation and suggest that P2X 2/3 R is activated by ATP.
P2 purinergic receptors:
Several lines of evidence suggest that P2X 2/3 R is the P2R subtype that mediates the action of ATP on left ventricular vagal sensory nerve terminals in the canine heart. The P2XRs receptors, seven of which have been cloned heretofore, are ligand-binding cationic channels that are commonly found on excitable cells. Their signal transduction pathways are membrane delimited, which enable rapid response to agonist activation that suits well a role in neurotransmission in general and rapid activation of central and local reflex loops in particular (4, 16) . Homomeric P2X 2 R and heteromeric P2X 2/3 R are found on peripheral terminals of small diameter sensory neurons (6, 15, 33) , and a phenotype characterized by co-expression of P2X 2 R and P2X 2/3 R is found in nodose ganglion cells (29) . Thus, it is not surprising that localized application of ATP at the canine epicardial sites triggers afferent neural traffic in the nodose ganglion (2).
We have previously shown that in the canine heart, intra-left coronary , -methylene-ATP ( mATP) is a potent stimulator of left ventricular vagal afferent nerve terminals (13) . Of the seven P2XR, only the homomeric P2X 1 R, P2X 2 R and P2X 3 R as well as the heteromeric P2X 2/3 R , are sensitive to mATP (32) . P2X 1 and P2X 3 are rapidly desensitized following stimulation by agonists, however, in the present model, repeated administrations of ATP and its similarly active analogues were not associated with desensitization, thus arguing against the involvement of P2X 1 R and P2X 3 R in this action of ATP. In addition, Ip 5 I, a P2X 3 R but not P2X 2/3 R antagonist (8), did not alter the action of ATP. Taken together, these observations suggest that P2X 2/3 R mediates the action of ATP on vagal sensory nerve terminals in the left ventricle of the canine heart. Indeed, P2X 2/3 R does not exhibit rapid desensitization, it is sensitive to mATP, and is potently blocked by TNP-ATP (16) . That TNP-ATP completely abolished the vagal reflex triggered by intra-coronary ATP in the present study is in congruence with the aforementioned conclusion.
Type of afferent fibers:
It is of interest to note that ATP can also generate afferent neural activity in capsaicin-sensitive vagal C fibers by stimulating bimodal (i.e., chemo-and mechanosensitive) nerve terminals in the canine lungs by activating P2XR (19) . The ability of P2XR agonists to induce C fiber dependent nociception has already been demonstrated (9) . Whether this action of ATP on pulmonary C fiber nerve terminals is responsible for neurogengic (i.e., vagal-dependent) bronchoconstriction induced by ATP (14) remains to be determined because ATP can also stimulate the pulmonary rapidly adapting receptors (RAR) of afferent A fibers (Pelleg et al., unpublished data). The ability of ATP to stimulate both capsaicin-sensitive (i.e., C fibers) and capsaicininsensitive (A ) sensory nerve terminals is in agreement with previous observations of ATP-induced inward current in capsaicin-sensitive and capsaicin-insensitive small-sized and medium sized dorsal root ganglion neurons, respectively (31) . While the type of fibers carrying the ATP-induced afferent neural activity from the heart has not been studied heretofore, several lines of evidence suggest that ATP stimulates the capsaicininsensitive (A ) sensory fibers rather than the C fibers. Specifically, heteromeric P2X 2/3 R mediates the activation by ATP of capsaicin-insensitive primary afferent neurons (30) . In addition, cell bodies of sensory A and C fibers are located in the nodose and jugular ganglion, respectively (35) , and accordingly, VR1 capsaicin receptor transcripts were not detected in nodose ganglia (5) . Finally, ATP stimulates epicardial mechano-and chemosensitive afferent nerve terminals whose cell bodies are in the nodose ganglion (2) . Taken together, these data indicate that extracellular ATP stimulates sensory vagal afferent A terminals in the left ventricle by activating P2X 2/3 R.
Physiological and clinical implications:
Cardiopulmonary bimodal (mechano-and chemosensitive) vagal sensory nerve terminals in the left ventricle have been implicated in the mechanism of vasovagal syncope (1) . Specifically, it is believed that the initial autonomic response in the syncope cascade of events of increased sympathetic input to the heart, caused by the drop of systemic blood pressure, is followed by a paradoxical increase in vagal input to the heart and sympathetic withdrawal mediated by the cardiopulmonary receptors including left ventricular mechano-sensitive vagal nerve terminals. Thus, instead of initiating a reflex response that would accommodate the hemodynamic stress, the ensuing vagal afferent activity ultimately triggers inappropriate vasodilation and bradycardia that lead to syncope (3). Since extracellular ATP can also activate these receptors, it is tempting to speculate that ATP could be mechanistically involved in vasovagal syncope as one of the endogenous mediators postulated to enhance the sensitivity of the cardiopulmonary receptors responsible for the paradoxical increase in vagal input to the heart. Indeed, in seven out of 30 patients with unexplained syncope and a negative baseline head-up-tilt-table test (HUT), the administration of ATP (intravenous bolus) prior to a second HUT resulted in a positive test (25) .
ATP and adenosine are released into the extracellular space under pathophysiologic conditions associated with acute myocardial ischemia (23) . Adenosine has been implicated with anginal pain through the activation of sympathetic chemosensitive nerve endings (27, 28) . Atropine responsive brady-arrhythmias associated with acute myocardial infraction have been hypothesized to be mediated by a vagal reflex triggered within the heart (7, 34) . Thus, on the basis of previous and present data it can be hypothesized that ATP is a mediator locally released during acute myocardial infarction that play a mechanistic role in the associated bradyarrhythmias by activating the P2X 2/3 R receptors on vagal sensory nerve terminals.
Figure Legends Figure 1
A typical example of the differential effects of adenosine and ATP (0.1 :mol/kg) given as a bolus injection into the right coronary artery (RCA; upper panel) and left circumflex coronary artery (LCA; lower panel) of the same animal. Given into the RCA, neither adenosine nor ATP altered heart rate. Given into the LCA, adenosine had no effect on heart rate; however, ATP exerted a pronounced transient negative chronotropic effect that commenced in less than two seconds after its administration. Arrowhead marks the time of administration of either ATP or adenosine. 
